Monitor for actual execution of this sale on Form 4 filings. A large insider sale by a 10% holder could signal reduced conviction, but the stock has strong analyst consensus (93% bullish) and a history of positive post-report drift. Watch for any subsequent Form 4 filings to confirm the sale.
Price Chart
Executive Summary
Cambrian BioPharma Inc, a 10% stockholder of Faeth Therapeutics, filed a Form 144 notice of intent to sell 130,142 shares of common stock, with an estimated aggregate market value of approximately $3.64 million. The shares were acquired in a private placement in January 2020. This represents a notable insider selling signal from a major shareholder, though the sale is not yet executed and the filing is an advance notice of intent.
Key Facts
- Cambrian BioPharma Inc, a 10% stockholder, filed a Form 144 to sell 130,142 shares of Faeth Therapeutics common stock.
- The estimated aggregate market value of the proposed sale is approximately $3.64 million based on a 07/22/2026 trade date.
- Shares were acquired in a private placement on 01/10/2020.
- The filing date is 08/11/2026, and the sale is planned through Fidelity Brokerage Services LLC.
Financial Impact
Proposed sale of 130,142 shares valued at approximately $3.64 million, representing about 0.5% of the company's $738M market cap.
Risk Factors
- Insider selling by a major shareholder may indicate reduced confidence in near-term prospects.
- The sale is not yet executed; the filing only signals intent, and the insider may not follow through.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-005879 |
| Document: 0001959173-26-005879-index.html | 0001959173-26-005879 |
| Document: 0001959173-26-005879.txt | 0001959173-26-005879 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 3 | $34.24 $31.55 | ▼ −7.86% | ▼ −10.42% | $28.35 (−17.20%) |
Aug 11, 2026 7w ago | 144 | $28.57 $33.00 | ▼ −15.51% | ▼ −15.91% | $28.35 (+0.77%) |
Aug 4, 2026 8w ago | 8-K | $25.50 $30.00 | ▲ +17.65% | ▲ +17.75% | $28.35 (+11.18%) |
Jul 28, 2026 9w ago | 3 | $28.93 $24.59 | ▼ −15.00% | ▼ −20.53% | $28.35 (−2.00%) |
Jul 2, 2026 13w ago | Insider Cluster | $22.92 $32.54 | ▲ +41.97% | ▲ +41.04% | $28.35 (+23.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access